Crinetics Pharmaceuticals income from continuous operations for the twelve months ending September 30, 2024 was $-0.278B, a 39.36% increase year-over-year.
Crinetics Pharmaceuticals annual income from continuous operations for 2023 was $-0.215B, a 30.88% increase from 2022.
Crinetics Pharmaceuticals annual income from continuous operations for 2022 was $-0.164B, a 52.28% increase from 2021.
Crinetics Pharmaceuticals annual income from continuous operations for 2021 was $-0.108B, a 45.83% increase from 2020.
Crinetics Pharmaceuticals Income from Continuous Operations 2017-2024 | CRNX